February 28, 2026 10:39 AM
Sun Pharmaceutical Industries Ltd Tumbles -2.73% in Today's Trading Session
After a -2.73% decline, Sun Pharmaceutical Industries Ltd shares are now trading at 1737.00. The stock has a PE ratio of 38.0700, an ROE of 14.8407 and a debt to equity ratio of 0.0670.
February 28, 2026 10:09 AM
Live Market Data: Sun Pharmaceutical Industries Ltd Share Price Drops -2.73% Today
Sun Pharmaceutical Industries Ltd's share price has fallen by -2.73%, presenting both challenges and opportunities for investors. As of now, it's trading at 1737.00, and market participants are assessing the implications. The stock has a PE ratio of 38.0700, an ROE of 14.8407 and a debt to equity ratio of 0.0670.
February 28, 2026 9:39 AM
Live Updates: Sun Pharmaceutical Industries Ltd Stock Falls Today
Sun Pharmaceutical Industries Ltd witnessed a -2.73% decrease in its share price, and it is currently trading at 1737.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 38.0700, an ROE of 14.8407 and a debt to equity ratio of 0.0670.
February 28, 2026 9:09 AM
Sun Pharmaceutical Industries Ltd Share Price in Red Today
Sun Pharmaceutical Industries Ltd share price has declined by -2.73%, and it's currently trading at 1737.00. The stock maintains a PE of 38.0700, while the industry PE is 32.4990, prompting discussions about its valuation.
February 28, 2026 8:38 AM
Live Updates: Sun Pharmaceutical Industries Ltd Stock Price Declines Today
Sun Pharmaceutical Industries Ltd's share price has fallen by -2.73%, a situation worth noting. At present, the stock is trading at 1737.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 38.0700, while the industry PE ratio is 32.4990.
February 28, 2026 8:09 AM
Today's Trading Session: Sun Pharmaceutical Industries Ltd Stock Falls
With a -2.73% decrease, Sun Pharmaceutical Industries Ltd's share price is now at 1737.00. The stock is currently trading at a PE of 38.0700, while the industry PE is 32.4990, prompting investors to assess its value proposition.
February 28, 2026 7:39 AM
Today's Trading Session: Sun Pharmaceutical Industries Ltd Share Price on the Decline
With a -2.73% decrease, Sun Pharmaceutical Industries Ltd's share price is currently at 1737.00. This development raises questions about the factors behind the decline. The stock's PE ratio is 38.0700, while the industry PE is 32.4990.
February 28, 2026 7:09 AM
Live Updates: Sun Pharmaceutical Industries Ltd Stock Price Declines Today
Sun Pharmaceutical Industries Ltd's share price has fallen by -2.73%, a situation worth noting. At present, the stock is trading at 1737.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 38.0700, while the industry PE ratio is 32.4990.
February 28, 2026 6:39 AM
Sun Pharmaceutical Industries Ltd Share Price Dips in Today's Trading
In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -2.73% in its share price, and it currently trades at 1737.00 per share. The stock has an ROE of 14.8407 and debt to equity ratio of 0.0670.
February 28, 2026 6:09 AM
Sun Pharmaceutical Industries Ltd Stock Slides Today
Sun Pharmaceutical Industries Ltd observed a -2.73% decrease in its share price, a situation that merits attention. As of now, it's actively trading at 1737.00. The stock has a PE ratio of 38.0700, an ROE of 14.8407 and a debt to equity ratio of 0.0670.
February 28, 2026 5:39 AM
Sun Pharmaceutical Industries Ltd Share Price Falls -2.73% in Today's Trading Session
Sun Pharmaceutical Industries Ltd witnessed a -2.73% drop in its share price and is currently trading at 1737.00. With the stock's PE at 38.0700 and the industry PE at 32.4990, investors are weighing their options.
February 28, 2026 5:08 AM
Live Market Data: Sun Pharmaceutical Industries Ltd Share Price Down -2.73% Today
Sun Pharmaceutical Industries Ltd shares saw a -2.73% decrease, reaching a current market price of 1737.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 38.0700, an ROE of 14.8407 and a debt to equity ratio of 0.0670.